Abstract

<p style="text-align: justify;"><strong>Background:</strong> Eczema is a chronic, usual, non-infective inflammatory state characterized by intense pruritis, redness, and swelling. Eczema patients experience mild to severe systemic symptoms such as itching, pain, and sleep disturbances, resulting in a significantly diminished quality of life. <strong>Methods: </strong>This prospective observational study was conducted for six months to study the prescribing pattern of various drugs in eczema patients in the outpatient department of dermatology. 86 anti-eczema prescriptions were analyzed. Factors considered were age, gender, types of diagnosis, site of the disease, and anti-eczema drugs prescribed. <strong>Results:</strong> Out of 86 patients, females (53.5%) were more than males (46.5%). The majority of the patients (44.18%) belonged to the age group 21 to 40 years and allergic contact dermatitis was the most common (39.53%) and most commonly affected was lower limb (43.02%). Most drugs prescribed were topical agents (60.38%) when compared to oral drugs (39.62%). Antihistamines (37.68%) were found to be the most commonly prescribed medication class. Levocetirizine (25.60%) was the most common drug prescribed in this study. Most of the prescriptions contained at least two drugs (61.63%). <strong>Conclusion:</strong> A clinical pharmacist can help improve a patient&rsquo;s quality of life by assisting with prescription analysis and prescribing patterns. Studies can assist in providing feedback to physicians on current prescribing practices. <p style="text-align: justify;"><strong>Key words:</strong> Prescribing pattern, Anti-eczema drugs, Levocetirizine, Eczema, Dermatology.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.